This interest in Alphabet's robotaxi company signals a shift in investor confidence around driverless technology.
The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results